Inactive Instrument
Nutritional High International Inc. Stock Canadian Securities Exchange
Stocks
EAT
CA6706848778
Pharmaceuticals
OTC Markets Traded| Market Cap | 1.72M 1.55M 1.41M 1.29M 2.43M 162M 2.51M 17.02M 6.79M 86.42M 6.47M 6.33M 273M | P/E 2021 |
-111x | P/E 2022 | -0.03x |
|---|---|---|---|---|---|
| Enterprise Value | 13.07M 11.72M 10.71M 9.78M 18.42M 1.23B 19M 129M 51.48M 655M 49.05M 47.99M 2.07B | EV / Sales 2021 |
224x | EV / Sales 2022 | 2.02x |
| Free-Float |
80.7% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -4.00% |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Willetts
DFI | Director of Finance/CFO | 63 | 2023-03-30 |
| Chief Tech/Sci/R&D Officer | - | 2018-06-10 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 2015-06-10 | |
Rachel Wright
BRD | Director/Board Member | - | 2022-06-19 |
Austin Birch
BRD | Director/Board Member | - | 2023-01-19 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.00% | -11.11% | - | - | 178K | |
| -0.79% | -4.48% | +44.44% | +127.49% | 1,206B | |
| +1.43% | +1.11% | +47.73% | +82.08% | 665B | |
| +1.07% | -1.21% | +32.99% | +106.31% | 515B | |
| -0.36% | -3.25% | +47.17% | +64.58% | 381B | |
| -0.14% | -1.87% | +71.05% | +40.63% | 362B | |
| -0.78% | -0.52% | +30.57% | +57.98% | 307B | |
| -0.80% | -0.21% | +8.54% | +35.56% | 289B | |
| +0.03% | -1.20% | +45.89% | +68.76% | 249B | |
| -0.41% | -2.22% | +35.24% | +105.68% | 207B | |
| Average | -0.48% | -1.54% | +40.40% | +76.56% | 464.42B | |
| Weighted average by Cap. | -0.04% | -1.96% | +42.24% | +88.38% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 96.07K 86.16K 78.75K 71.88K 135K 9.03M 140K 949K 378K 4.82M 361K 353K 15.21M | 6.25M 5.6M 5.12M 4.68M 8.81M 587M 9.09M 61.74M 24.62M 313M 23.45M 22.95M 989M |
| Net income | -1.85M -1.66M -1.52M -1.38M -2.61M -174M -2.69M -18.27M -7.29M -92.77M -6.94M -6.79M -293M | -18.97M -17.01M -15.55M -14.19M -26.74M -1.78B -27.59M -187M -74.74M -952M -71.21M -69.68M -3B |
| Net Debt | 6.1M 5.47M 5M 4.56M 8.6M 573M 8.87M 60.25M 24.03M 306M 22.89M 22.4M 966M | 11.34M 10.17M 9.3M 8.49M 15.99M 1.07B 16.5M 112M 44.69M 569M 42.58M 41.67M 1.8B |
Employees
-
Sector
Pharmaceuticals
